Minerva Neurosciences, Inc.
NERV
$4.80
$0.061.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -125.40M | -283.67M | -2.74M | -3.26M | -3.75M |
| Total Depreciation and Amortization | -- | 1.40K | 1.40K | 1.40K | 1.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.93M | 279.67M | 272.90K | 298.20K | 297.20K |
| Change in Net Operating Assets | 2.04M | -485.20K | -446.40K | 916.90K | -617.60K |
| Cash from Operations | -5.43M | -4.48M | -2.92M | -2.04M | -4.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.29M | -- | -- | -- | -- |
| Cash from Investing | -45.29M | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.20M | 80.00M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.90K | -5.50M | -45.20K | -- | -- |
| Cash from Financing | 1.08M | 74.50M | -45.20K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.64M | 70.02M | -2.96M | -2.04M | -4.07M |